Epsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease.

scientific article

Epsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(70)91789-7
P698PubMed publication ID4192381

P2093author name stringH R Gralnick
P2860cites workThe control of dicumarol therapy and the quantitative determination of prothrombin and proconvertinQ34297456
The mechanism of clot dissolution by plasminQ40330962
On the Quantitative Estimation of ProthrombinQ47780898
New one-stage procedures for the quantitative determination of prothrombin and labile factorQ47972843
Allwork SP: Fibrinolysis and bleeding in open-heart surgery.Q54176648
Heparin treatment of haemorrhagic diathesis in cyanotic congenital heart-disease.Q54525850
Fibrinolysis in congenital heart disease. Preoperative treatment with epsilon-aminocaproic acidQ72341448
Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapyQ72372191
An improved micro hematocrit methodQ73603655
Morphology and enumeration of human blood plateletsQ75602485
P433issue7658
P407language of work or nameEnglishQ1860
P304page(s)1204-1205
P577publication date1970-06-01
P1433published inThe LancetQ939416
P1476titleEpsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease.
P478volume1

Reverse relations

cites work (P2860)
Q93706191Anticoagulants in rheumatic heart-disease
Q41546723Aspirin, thrombosis, and the future
Q71656410Coagulation abnormalities in cyanotic heart disease
Q33461237Consumption coagulopathy in congenital heart-disease
Q93706193Correction of haemostatic defect in cyanotic congenital heart-disease
Q39912829Disorders of Fibrinolysis
Q44948870Dose comparison of tranexamic acid in pediatric cardiac surgery
Q50474469Dynamics of factor XIII levels after open heart surgery for congenital heart defects: do cyanotic and acyanotic patients differ?
Q73198465Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease
Q41238758Excess intravascular coagulation complicating low cardiac output
Q70599235Fibrinogen half-life in children with cyanotic congenital heart disease
Q36763257Haemostatic defects in cyanotic congenital heart disease
Q39919252Hematologic Effects of Cardiac Disease
Q35314506Natural and synthetic antifibrinolytics in cardiac surgery
Q68998780Preoperative evaluation of hemostasis in patients with congenital heart disease

Search more.